[Form 4] Wolverine World Wide, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Wolverine World Wide director and Chief Human Resources Officer Amy M. Klimek reported transactions on 08/18/2025 involving company common stock and an option. Ms. Klimek exercised a stock option for 18,676 shares at an exercise price of $22.92, resulting in 18,676 shares acquired. On the same date she sold 18,676 shares under a Rule 10b5-1 trading plan at a weighted average price of $28.41 and sold an additional 20,000 shares at the same weighted average price. After these transactions her direct ownership is reported as 0 shares and she retains indirect beneficial ownership of 35,989 shares held by the Austin Family Living Trust, of which she and her husband are trustees.

Positive

• Transactions disclosed under a Rule 10b5-1 plan, indicating pre-planned and compliant insider sales
• Option exercise followed by sales at a higher weighted average price (exercise $22.92; sales weighted avg $28.41)

Negative

• Reporting person’s direct ownership reduced to 0 shares after the transactions
• Significant insider sales totaling 38,676 shares may be perceived negatively by some investors

Insights

Financial Analyst

TL;DR: Insider exercised options and executed sizable Rule 10b5-1 sales, leaving no direct holdings while retaining trust-held shares.

The filing shows a typical option exercise followed by planned dispositions under a 10b5-1 plan adopted May 27, 2025. The option exercise price was $22.92 and the subsequent sales realized a weighted average price of $28.41, indicating the insider monetized appreciated option exposure. From an investor-perspective this is a liquidity event rather than an operational signal; ownership moved from direct to trust-held indirect ownership of 35,989 shares. No indications of unusual timing or undisclosed private transactions are present in the filing.

Corporate Governance Expert

TL;DR: Transactions adhere to a pre-established 10b5-1 plan and are disclosed appropriately, but eliminate the reporting person’s direct stake.

The Form 4 discloses that sales were effected pursuant to a Rule 10b5-1 trading plan adopted May 27, 2025, which provides the affirmative defense to insider trading claims when properly structured. The reporting person now shows zero direct shares and retains indirect holdings via a family trust. For governance review, the clear disclosure of plan adoption date, weighted average sale price range, and trust holdings supports compliance and transparency, though some stakeholders may note the complete elimination of direct ownership.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Klimek Amy M.

(Last) (First) (Middle)

C/O 9341 COURTLAND DRIVE NE

(Street)

ROCKFORD MI 49351

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
WOLVERINE WORLD WIDE INC /DE/ [ WWW ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Human Resources Officer

3. Date of Earliest Transaction (Month/Day/Year)
08/18/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/18/2025		M		18,676	A	$22.92	18,676	D
Common Stock	08/18/2025		S(1)		18,676	D	$28.41(2)	0	D
Common Stock	08/18/2025		S(1)		20,000	D	$28.41(2)	35,989	I(3)	By Trust

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$22.92	08/18/2025		M			18,676	(4)	07/12/2026	Common Stock	18,676	$0	0	D

Explanation of Responses:

1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 27, 2025.

2. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $27.76 to $28.62. The reporting person undertakes to provide to Wolverine World Wide, Inc., any security holder of Wolverine World Wide, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.

3. Shares held by the Austin Family Living Trust, of which the reporting person and her husband are the trustees.

4. The Stock Option vested in three installments of 1/3 each on July 13, 2017, July 13, 2018 and July 13, 2019.

Remarks:

	/s/ David Latchana by Power of Attorney	08/20/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What trades did Amy M. Klimek report for WWW on 08/18/2025?

She exercised 18,676 option shares at $22.92 and sold 18,676 shares and an additional 20,000 shares on 08/18/2025 under a 10b5-1 plan.

Were the sales executed under a pre-arranged trading plan for WWW insider trades?

Yes. The sales were effected pursuant to a Rule 10b5-1 trading plan adopted May 27, 2025.

What were the prices for the exercised options and the sold shares in the WWW Form 4?

Option exercise price: $22.92 per share. Weighted average sale price: $28.41 per share (sales ranged $27.76 to $28.62).

How many WWW shares does Ms. Klimek beneficially own after the reported transactions?

Direct ownership: 0 shares. Indirect ownership: 35,989 shares held by the Austin Family Living Trust.

Who holds the indirect shares reported by Amy M. Klimek?

The Austin Family Living Trust, of which Ms. Klimek and her husband are the trustees.